[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352859-105":59,"doc-detail-352859-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","a-small-molecule-disrupts-g4-stat1-interaction-and-synergizes-with-olaparib-to-drive-cancer-cell-death","A small molecule disrupts G4-STAT1 interaction and synergizes with olaparib to drive cancer cell death","","Bloom syndrome protein (BLM), a RecQ family DNA helicase, is consistently overexpressed in multiple malignancies, yet its therapeutic potential remains largely unexplored. The study targets the BLM promoter G-quadruplex (BLM-G4) to inhibit BLM signaling, showing that BLM-G4 recruits pSTAT1 to activate BLM expression. Berberine and coptisine disrupt STAT1 binding to BLM-G4, suppress BLM expression in colon cancer, and synergize with olaparib.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-small-molecule-disrupts-g4-stat1-interaction-and-synergizes-with-olaparib-to-drive-cancer-cell-death/352859/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-small-molecule-disrupts-g4-stat1-interaction-and-synergizes-with-olaparib-to-drive-cancer-cell-death/352859.png","ImageObject",300,407,{"name":92,"@type":93},"Bintang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What therapeutic strategy does the study focus on for BLM?","Question",{"text":112,"@type":113},"It targets the BLM promoter G-quadruplex (BLM-G4) to inhibit the BLM signaling pathway and disrupt downstream DNA repair functions.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do berberine and coptisine affect the BLM-G4/STAT1 axis?",{"text":117,"@type":113},"They compete with STAT1 for binding to BLM-G4, thereby suppressing BLM expression in colon cancer cells.",{"name":119,"@type":110,"acceptedAnswer":120},"What is the combined effect of BER/COP with olaparib?",{"text":121,"@type":113},"BER/COP shows a pronounced synergistic effect with olaparib in inducing colon cancer cell death by disrupting DNA repair pathways and intensifying DNA damage.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},352859,1790198799,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962085564381,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","A small molecule disrupts G4–STAT1 interaction and synergizes with olaparib to drive cancer cell death  \nYingying Wang1 ,†, Xuenan Zhang2 ,†, Yuting Bian1 ,†, Sihan He1 , Rongshuang Cheng1 , Jinzhu Li1 , Jonathan Dickerhoff 3 , Yushuang Liu1 , Yu Zhou1 , Jinlei Bian1 , Kewei Zheng 2 ,* ,  \nDanzhou Yang 3 ,* , Ling-Yi Kong1 ,* , Kai-Bo Wang1 ,*  \n1 State Key Laboratory of Natural Medicines, Joint International Research Laboratory of Target Discovery and New Drug Innovation (Ministry of Education), and Jiangsu Key Laboratory of Bioactive Natural Product Research, China Pharmaceutical University, Nanjing, Jiangsu 211198, PR China  \n2 School of Biomedical Sciences, Hunan University, Changsha, Hunan 410082, PR China  \n3 Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN 47907, America  \n∗ To whom correspondence should be addressed. Email: [kbwang@cpu.edu.cn](kbwang@cpu.edu.cn)  \nCorrespondence may also be addressed to Ling-Yi Kong. Email: [cpu_lykong@126.com](cpu_lykong@126.com)  \nCorrespondence may also be addressed to [Danzhou Yang. Email:](Danzhou Yang. Email: yangdz@purdue.edu)[ yangdz@purdue.edu](Danzhou Yang. Email: yangdz@purdue.edu)  \nCorrespondence may also be addressed to Kewei Zheng. Email: [zhengkewei@hnu.edu.cn](zhengkewei@hnu.edu.cn)  \n†The first three authors should be regarded as Joint First Authors.  \nAbstract  \nBloom syndrome protein (BLM), a RecQ family DNA helicase, is consistently overexpressed in multiple malignancies, yet its therapeutic potential remains largely unexplored. Herein, we focused on targeting the BLM promoter G-quadruplex ( BLM-G4) to inhibit the BLM signaling pathway. We first characterized the parallel BLM-G4 in the BLM promoter region. Subsequently, it is shown for the first time that BLM-G4 recruits phosphorylated signal transducer and activator of transcription 1 (pSTAT1) to activate BLM expression. Importantly, two natural alkaloids, berberine (BER) and coptisine (COP), compete with STAT1 for binding to BLM-G4, thereby significantly suppressing BLM expression in colon cancer cells. The BER/COP−BLM-G4 complex structures were determined using nuclear magnetic resonance experiments, which provide valuable insights for the rational design of next-generation BLM-G4-targeting ligands. Beyond BLM regulation, the conjoint analysis of genomewide STAT1-CUT&Tag-seq, G4-CUT&Tag-seq, and COP-RNA-seq demonstrated STAT1 as a general G4-binding transcription factor and COP as a pan-genomic G4 stabilizer. Furthermore, BER/COP exhibited a pronounced synergistic effect with olaparib in inducing colon cancer cell death by disrupting DNA repair pathways and intensifying DNA damage. Collectively, our findings reveal a novel epigenetic mechanism of BLM gene upregulation mediated by BLM-G4−STAT1 interaction and suggest that the combination therapy of G4 stabilizers with poly(ADP) ribose polymerase (PARP) inhibitors is a promising strategy for treating complex cancers.  \nGraphical abstract  \nReceived: September 5, 2025 . Accepted: April 1, 2026  \n© The Author(s) 2026 . Published by Oxford University Press.  \nThis is an Open Access article distributed under the terms of the Creative Commons Attribution License ([https://creativecommons.org/licenses/by/4.0/](https://creativecommons.org/licenses/by/4.0/)), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.  \n2 Wang et al.  \nIntroduction  \nBLM (Bloom syndrome protein), a member of the RecQ family DNA helicases, plays a crucial role in unwinding various aberrant nucleic acid secondary structures, such as Gquadruplexes (G4s), DNA displacement loops (D-loops), and Holliday junctions, and thus suppresses aberrant recombination at these sites and maintains genome stability [1, 2] . Additionally, BLM is characterized as a critical upstream component for the recruitment of homologous recombination (HR) and canonical non-homologous end joining (c-NHEJ) f","cbCaifxAUxgXZ6oA","https://ap.wps.com/l/cbCaifxAUxgXZ6oA","pdf",6815196,18,"English","# Abstract\n## Introduction\n## Received and publication information","[{\"question\":\"What therapeutic strategy does the study focus on for BLM?\",\"answer\":\"It targets the BLM promoter G-quadruplex (BLM-G4) to inhibit the BLM signaling pathway and disrupt downstream DNA repair functions.\"},{\"question\":\"How do berberine and coptisine affect the BLM-G4/STAT1 axis?\",\"answer\":\"They compete with STAT1 for binding to BLM-G4, thereby suppressing BLM expression in colon cancer cells.\"},{\"question\":\"What is the combined effect of BER/COP with olaparib?\",\"answer\":\"BER/COP shows a pronounced synergistic effect with olaparib in inducing colon cancer cell death by disrupting DNA repair pathways and intensifying DNA damage.\"}]","A small molecule disrupts G4-STAT1 interaction and synergizes with olaparib to drive cancer cell death | PDF",1790101772,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1a74e00e43a8d9530434b097a1f38887.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/09ca5e14119750c1130f8dac2ada43e7.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2c6bde55b15e9be8c631990bd3c7b6c9.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/79ead2335203b4b3eb48b61639c60cf6.webp",980,1268]